APA (7th ed.) Citation

C, P., H, H., H, F., T, C., & J, T. (2026). METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review). International journal of oncology, 68(6), . https://doi.org/10.3892/ijo.2026.5884

Chicago Style (17th ed.) Citation

C, Pu, Hu H, Fan H, Chen T, and Tang J. "METTL3 in Esophageal Cancer: Current Insights into Molecular Mechanisms, Subtype Heterogeneity and Targeted Therapy Prospects (Review)." International Journal of Oncology 68, no. 6 (2026). https://doi.org/10.3892/ijo.2026.5884.

MLA (9th ed.) Citation

C, Pu, et al. "METTL3 in Esophageal Cancer: Current Insights into Molecular Mechanisms, Subtype Heterogeneity and Targeted Therapy Prospects (Review)." International Journal of Oncology, vol. 68, no. 6, 2026, https://doi.org/10.3892/ijo.2026.5884.